Heart Failure in Dilated Cardiomyopathy

  • C. Perret
Conference paper
Part of the Update in Intensive Care and Emergency Medicine book series (UICM, volume 1)


Dilated (congestive) cardiomyopathy (DCM) is defined as a heart muscle disease of unknown etiology characterized by a severe impairment of systolic function, responstible for a progressive ventricular dilatation. In most cases, both ventricles are simultaneously involved but occasionnally a right ventricular pump failure precedes the left ventricular failure. Many associated or conditioning factors have been incriminated including prolonged alcohol abuse, malnutrition, pregnancy/puerperium, small coronary-vessel disease, viral infection, persistent inflammation with disorders of cellular immunity.


Left Ventricular Failure Congestive Cardiomyopathy Acute Left Ventricular Failure Progressive Ventricular Dilatation Diastolic Ventricular Volume 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies (1980) Br Heart J 44: 672CrossRefGoogle Scholar
  2. 2.
    Goodwin JF (1982) The frontiers of cardiomyopathy. Br Heart J 48: 1CrossRefGoogle Scholar
  3. 3.
    Goodwin JF (1970) Congestive and hypertrophic cardiomyopathies. A decade of study. Lancet i: 731Google Scholar
  4. 4.
    Abelmann WH (1984) Classification and natural history of primary myocardial disease. Prog Cardiovas Dis 27: 73CrossRefGoogle Scholar
  5. 5.
    Leier CV, Unverferth DV (1983) Dobutamine. Ann Int Med 99: 490Google Scholar
  6. 6.
    Leier CV, Heban PT, Huss P et al (1978) Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure. Circulation 58: 466PubMedCrossRefGoogle Scholar
  7. 7.
    Loeb HS, Bredakis J, Gunnar RM (1977) Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure. Circulation 55: 375PubMedCrossRefGoogle Scholar
  8. 8.
    Rossen RM, Aldermann EL, Harrison DC (1976) Circulatory response to vasodilator therapy in congestive cardiomyopathy. Br Heart J 38: 695PubMedCrossRefGoogle Scholar
  9. 9.
    Cody RJ (1984) Angiotensin II-mediated vasoconstriction in chronic congestive heart failure and response to converting enzyme inhibition. Am J Med 77 Suppl 71Google Scholar
  10. 10.
    Goldberg LI (1978) Dopamine and dobutamine. Brit Med J 2: 1163Google Scholar
  11. 11.
    Sharma B, Goodwin JF (1978) Beneficial effect of salbutamol on cardiac function in severe congestive cardiomyopathy. Effect on systolic and diastolic function of the left ventricle. Circulation 58: 450Google Scholar
  12. 12.
    Turini GA, Brunner HR, Grbic et al (1979) Improvement of chronic congestive hart failure by oral captopril. Lancet 1: 1213PubMedCrossRefGoogle Scholar
  13. 13.
    Levine TB, Olivari MT, Cohn JN (1984) Hemodynamic and regional blood flow response to captogril in congestive heart failure. Am J Med 76: 38PubMedCrossRefGoogle Scholar
  14. 14.
    Cleland JGF, Dargie HJ, Hodsman GP et al (1984) Captopril in heart failure. A double blind controlled trial. Br Heart J 52: 530Google Scholar
  15. 15.
    Cody RJ (1985) Clinical and hemodynamic experience with enalapril in congestive heart failure. Am J Cardiol 55: 36AGoogle Scholar
  16. 16.
    DiCarlo L, Chatterjee K, Parmley WW et al (1983) Enalapril: A new angiotensin-converting enzyme inhibitior in chronic heart failure: acute and chronic hemodynamic evaluations. J Am Coll Cardiol 2: 865PubMedCrossRefGoogle Scholar
  17. 17.
    Sharpe DN, Murphy J, Coxon R, Hannan SF (1984) Enalapril in patients with chronic heart Failure: a placebo-controlled, randomized, double-blind study. Circulation 70: 271PubMedCrossRefGoogle Scholar
  18. 18.
    Franciosa JA, Wilen MM, Jordan RA (1985) Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure. J Am Coll Cardiol 5: 101PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • C. Perret

There are no affiliations available

Personalised recommendations